Equities Research Analysts’ updated eps estimates for Monday, February 9th: Aardvark Therapeutics (NASDAQ:AARD) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $40.00 target price on the stock. Affirm (NASDAQ:AFRM) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $85.00 target price on the [...]
Equities Research Analysts’ Updated EPS Estimates for February 9th (AARD, AFRM, BVS, CNC, DAVE, DBD, DEVO, ENTX, ERIC, ESLA)
